Search results
NovAccess Global Announces New License to Advance its Immunotherapy Platform
Digital Journal· 3 days agoThe license pertains to the use of Isocitrate Dehydrogenase-1 (IDH1), a protein previously known to impact cell metabolism. The Company intends to leverage this license to ...
Stowers Institute for Medical Research appoints new Assistant Investigator
FOX 4 Kansas City· 3 days agoKamena Kostova, Ph.D., a molecular biologist from Carnegie Science, will open her lab at the Stowers Institute in Fall 2024. KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute ...
Opinion | Closing Gender-Based Disease Disparities Starts in the Lab
MedPage Today· 6 days agoDespite the fact men have lower life expectancy than women and are at a higher risk of developing...
Alzheimer's disease: What can AI teach us about the gut-brain link?
Medical News Today· 7 days agoResearch has suggested that the gut microbiome is disrupted in people with Alzheimer’s disease, and ...
This Chinese virologist shared crucial Covid-19 data. Then his research hit hurdles
CNN via AOL· 2 days agoScientist was lauded for his 2020 disclosure, but in the years since, people who know him say he has...
Stowers Institute for Medical Research appoints new Assistant Investigator
The Longview News-Journal· 3 days agoKamena Kostova, Ph.D., a molecular biologist from Carnegie Science, will open her lab at the Stowers Institute in Fall 2024. KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute ...
Stowers Institute for Medical Research appoints new Assistant Investigator
NBC 10 - FOX 14 Monroe· 3 days agoKamena Kostova, Ph.D., a molecular biologist from Carnegie Science, will open her lab at the Stowers Institute in Fall 2024. KANSAS CITY, Mo., April 30, 2024 /PRNewswire/ -- The Stowers Institute ...
For microscopic organisms, ocean currents act as ‘expressway’ to deeper depths, study finds
Newswise· 1 day agoSome of the ocean’s tiniest organisms get swept into underwater currents that act as a conduit that...
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
Benzinga· 2 days agoAnova to manage delivery of Phase 1/2a study of DB107 at UCSF, USC, UCSD and with Denovo Biopharma DB107 is a proprietary gene therapy platform for the treatment of patients with newly diagnosed high grade
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
InvestorPlace· 2 days agoWhile a weakening economy and a subsequent dip in the stock market are unfortunate, they are...